Josh Hulbert

Josh Hulbert has extensive experience in the pharmaceutical industry, currently serving as Executive Director at Bristol Myers Squibb since July 2015, where responsibilities include Global Commercial Oncology, Strategy, and Business Development. Prior roles at Bristol Myers Squibb encompass various leadership positions in hematology and thoracic marketing. Prior to this, Josh held significant roles at BioVid Corporation, Evolution Marketing Research, and GlaxoSmithKline, with a foundation in research as a Research Assistant at The Children's Hospital of Philadelphia. An academic background includes a B.S. in Business Administration with a focus on Economics and Entrepreneurship from Drexel University's LeBow College of Business.